BRPI0608505B8 - comprimido sublingual revestido - Google Patents

comprimido sublingual revestido

Info

Publication number
BRPI0608505B8
BRPI0608505B8 BRPI0608505A BRPI0608505A BRPI0608505B8 BR PI0608505 B8 BRPI0608505 B8 BR PI0608505B8 BR PI0608505 A BRPI0608505 A BR PI0608505A BR PI0608505 A BRPI0608505 A BR PI0608505A BR PI0608505 B8 BRPI0608505 B8 BR PI0608505B8
Authority
BR
Brazil
Prior art keywords
sublingual tablet
coated
coated sublingual
tablet
fentanyl
Prior art date
Application number
BRPI0608505A
Other languages
English (en)
Inventor
Herry Catherine
Benoist Guillaume
Duvochel Joseph
Oury Pascal
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of BRPI0608505A2 publication Critical patent/BRPI0608505A2/pt
Publication of BRPI0608505B1 publication Critical patent/BRPI0608505B1/pt
Publication of BRPI0608505B8 publication Critical patent/BRPI0608505B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Abstract

comprimido sublingual revestido. a presente invenção está relacionada a um comprimido sublingual revestido e ao método para a sua preparação. o comprimido compreende um núcleo sem uma substância farmaceuticamente ativa e um revestimento compreendendo pelo menos uma substância ativa. a substância ativa preferida é um analgésico opióide.
BRPI0608505A 2005-03-18 2006-03-20 comprimido sublingual revestido BRPI0608505B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0502727 2005-03-18
FR0502727A FR2883179B1 (fr) 2005-03-18 2005-03-18 Comprime enrobe
PCT/EP2006/003304 WO2006097361A1 (en) 2005-03-18 2006-03-20 Sublingual coated tablet

Publications (3)

Publication Number Publication Date
BRPI0608505A2 BRPI0608505A2 (pt) 2010-01-05
BRPI0608505B1 BRPI0608505B1 (pt) 2021-05-04
BRPI0608505B8 true BRPI0608505B8 (pt) 2021-05-25

Family

ID=35309611

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0608505A BRPI0608505B8 (pt) 2005-03-18 2006-03-20 comprimido sublingual revestido

Country Status (26)

Country Link
US (2) US8709479B2 (pt)
EP (1) EP1858491B1 (pt)
JP (1) JP5138577B2 (pt)
KR (1) KR101239926B1 (pt)
CN (1) CN101141951B (pt)
AT (1) ATE507824T1 (pt)
AU (1) AU2006224690B2 (pt)
BR (1) BRPI0608505B8 (pt)
CA (1) CA2599502C (pt)
CY (1) CY1111729T1 (pt)
DE (1) DE602006021713D1 (pt)
DK (1) DK1858491T3 (pt)
ES (1) ES2365984T3 (pt)
FR (1) FR2883179B1 (pt)
HK (1) HK1109730A1 (pt)
IL (1) IL185626A (pt)
MX (1) MX2007011440A (pt)
NO (1) NO338771B1 (pt)
NZ (1) NZ561154A (pt)
PL (1) PL1858491T3 (pt)
PT (1) PT1858491E (pt)
RU (1) RU2403043C2 (pt)
SI (1) SI1858491T1 (pt)
UA (1) UA88509C2 (pt)
WO (1) WO2006097361A1 (pt)
ZA (1) ZA200707900B (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1708685B1 (en) * 2003-12-31 2011-03-09 Cima Labs Inc. Effervescent oral opiate dosage forms and methods of administering oxycodone
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
WO2007087452A2 (en) * 2006-01-27 2007-08-02 Theraquest Biosciences, Llc Abuse resistant and extended release formulations and method of use thereof
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en) * 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
CN106727271B (zh) * 2006-01-06 2020-02-14 阿塞尔Rx制药有限公司 小体积口腔经粘膜剂型
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
DE102006054638B4 (de) * 2006-11-16 2014-12-04 Laburnum Gmbh Pharmazeutische Einzeldosisform
KR101445891B1 (ko) * 2007-01-05 2014-10-02 아셀알엑스 파마슈티컬스 인코퍼레이티드 경구 경점막 제형의 투여를 위한 저장 및 분배 장치
US20100010031A1 (en) 2007-02-09 2010-01-14 Yum Ii Su Transoral dosage forms comprising sufentanil and naloxone
CA2704929C (en) * 2007-08-07 2018-05-15 Pamela Palmer Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms
FR2920308B1 (fr) * 2007-09-05 2011-02-25 Unither Dev Forme pharmaceutique pour l'administration par voie orale de principes actifs.
CA2709905A1 (en) * 2007-12-17 2009-06-25 Alfred Liang Abuse-resistant oxycodone composition
US20090263476A1 (en) * 2008-04-16 2009-10-22 Jobdevairakkam Christopher N Composition of Rapid Disintegrating Direct Compression Buccal Tablet
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
ES2554626T3 (es) * 2009-06-12 2015-12-22 Cynapsus Therapeutics Inc. Apomorfina sublingual
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
US20110288128A1 (en) * 2010-05-21 2011-11-24 Acelrx Pharmaceuticals, Inc. Oral Transmucosal Administration of Sufentanil
EP2455069A1 (de) * 2010-11-11 2012-05-23 Laburnum GMBH Wirkstofffreie Darreichungsform, Verfahren zu deren Herstellung sowie deren Verwendung
AU2011346758C1 (en) * 2010-12-23 2015-09-03 Purdue Pharma L.P. Tamper resistant solid oral dosage forms
MX353623B (es) * 2011-05-13 2018-01-22 Eb Ip Hybritabs B V Sistema de suministro de farmaco.
CA2834327C (en) 2011-09-19 2017-05-30 Orexo Ab New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
US8815911B2 (en) 2012-05-02 2014-08-26 Orexo Ab Alfentanil composition for the treatment of acute pain
CN102755322B (zh) * 2012-07-24 2013-12-11 兆科药业（广州）有限公司 一种乐卡地平和阿托伐他汀复方制剂
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP2886103A1 (en) * 2013-12-23 2015-06-24 Hexal AG Pharmaceutical orodispersible film comprising buprenorphine particles with a particular size
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
EP3578164A1 (en) * 2018-06-05 2019-12-11 Bio-Gate AG Thixotropic composition
CN209673136U (zh) 2019-05-07 2019-11-22 深圳市华普森电子有限公司 高清智能一体化管道探测器

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL282752A (pt) * 1961-09-10
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
FR2621483B1 (fr) 1987-10-08 1991-09-20 Medibrevex Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation
US5202128A (en) 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
CA2147862A1 (en) * 1992-11-05 1994-05-11 Robert E. Dempski Drug delivery device
US5411745A (en) 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5744164A (en) 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
FR2771291B1 (fr) 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2769524B1 (fr) 1998-01-06 1999-12-31 Ethypharm Lab Prod Ethiques Dispositif d'enrobage pour granules a absorber par voie orale
FR2774910B1 (fr) * 1998-02-16 2001-09-07 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6248760B1 (en) * 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
US20010016593A1 (en) 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
FR2794646B1 (fr) 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
FR2796840B1 (fr) 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6602518B2 (en) * 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
DE20220910U1 (de) 2001-08-06 2004-08-05 Euro-Celtique S.A. Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden
US20030191147A1 (en) 2002-04-09 2003-10-09 Barry Sherman Opioid antagonist compositions and dosage forms
ES2270335T7 (es) * 2003-01-31 2012-03-16 Orexo Ab Composicion farmaceuta de efecto.
FR2855756B1 (fr) 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe

Also Published As

Publication number Publication date
FR2883179A1 (fr) 2006-09-22
PL1858491T3 (pl) 2012-03-30
CA2599502A1 (en) 2006-09-21
MX2007011440A (es) 2007-11-14
US20060210632A1 (en) 2006-09-21
FR2883179B1 (fr) 2009-04-17
CN101141951B (zh) 2011-02-09
JP2008533084A (ja) 2008-08-21
JP5138577B2 (ja) 2013-02-06
ES2365984T3 (es) 2011-10-14
NO338771B1 (no) 2016-10-17
RU2403043C2 (ru) 2010-11-10
PT1858491E (pt) 2011-08-18
CN101141951A (zh) 2008-03-12
KR20070114756A (ko) 2007-12-04
HK1109730A1 (en) 2008-06-20
AU2006224690A1 (en) 2006-09-21
SI1858491T1 (sl) 2011-09-30
CA2599502C (en) 2013-05-14
US8709479B2 (en) 2014-04-29
ATE507824T1 (de) 2011-05-15
WO2006097361A1 (en) 2006-09-21
KR101239926B1 (ko) 2013-03-07
IL185626A0 (en) 2008-01-06
EP1858491A1 (en) 2007-11-28
BRPI0608505B1 (pt) 2021-05-04
DE602006021713D1 (de) 2011-06-16
IL185626A (en) 2014-09-30
EP1858491B1 (en) 2011-05-04
CY1111729T1 (el) 2015-10-07
ZA200707900B (en) 2009-01-28
US20080226717A1 (en) 2008-09-18
NZ561154A (en) 2010-12-24
BRPI0608505A2 (pt) 2010-01-05
AU2006224690B2 (en) 2011-09-29
NO20075345L (no) 2007-12-17
DK1858491T3 (da) 2011-08-22
RU2007138647A (ru) 2009-04-27
UA88509C2 (ru) 2009-10-26

Similar Documents

Publication Publication Date Title
DK1858491T3 (da) Sublingual overtrukket tablet
UY3723Q (es) Aerosol
DK1848718T3 (da) E1 aktiveringsenzymhæmmere
DK1879623T3 (da) Genterapi til rygmarvssygdomme
DK1781618T3 (da) Sigma-receptorinhibitorer
DE602007005372D1 (de) Zweischichtige tablette zur verhinderung von kardiovaskulären ereignissen
DE602005015459D1 (de) Folienherstellungsverfahren
DE602006012689D1 (de) Überprüfungsverfahren
ITTO20050241A1 (it) Impianto dentario intraosseo.
NO20091386L (no) Fenyloksyanilinderivater
DE602006004709D1 (de) Beschichtungsverfahren
DK1962960T3 (da) Fremgangsmåde til mikornisering
UY3590Q (es) Microfono
DK1720557T3 (da) Hurtig-opløselig, smagsmaskeret tablet
DK1934388T3 (da) Fremgangsmåde til lægemiddeludvikling
UY3591Q (es) Microfono
ITBO20060023U1 (it) Orecchino pendente.
FI20041361A (fi) Pakkausmateriaalit
NO20044198L (no) Mikrofon
NO20045094L (no) Emballasje
TH86393B (th) จี้
ES1059640Y (es) Mantel con puntilla
ITFO20060009A1 (it) Decorazioni estetiche per abbigliamento-attrezzi-accessori sportivi-
FIU20040134U0 (fi) Purkainlaite
UA12469S (uk) Клеймо

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/03/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/03/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF